Tokyo, June 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061914) titled 'Switching from semaglutide to tirzepatide in obesity management: effects on body weight and metabolic parameters' on June 15.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - Aso clinic
Condition:
Condition - Obesity
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of the study is to evaluate the effects of switching to tirzepatide on body weight, body composition, and metabolic parameters, as well as its safety, in patien...